News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
332,352 Results
Type
Article (24497)
Company Profile (108)
Press Release (307747)
Section
Business (116572)
Career Advice (1091)
Deals (17031)
Drug Delivery (76)
Drug Development (34718)
Employer Resources (150)
FDA (6491)
Job Trends (8094)
News (174805)
Policy (13117)
Tag
Academia (1765)
Alliances (25497)
Alzheimer's disease (742)
Approvals (6502)
Artificial intelligence (134)
Bankruptcy (103)
Best Places to Work (6621)
Breast cancer (94)
Cancer (842)
Career advice (933)
CAR-T (63)
Cell therapy (179)
Clinical research (27588)
Collaboration (410)
Compensation (74)
COVID-19 (1247)
C-suite (111)
Data (817)
Diabetes (106)
Diagnostics (3551)
Earnings (48641)
Employer resources (129)
Events (48557)
Executive appointments (390)
FDA (6892)
Funding (330)
Gene therapy (121)
GLP-1 (341)
Government (1931)
Healthcare (8508)
Infectious disease (1309)
Inflammatory bowel disease (68)
Interviews (158)
IPO (7881)
Job creations (1771)
Job search strategy (836)
Layoffs (197)
Legal (2421)
Lung cancer (156)
Manufacturing (136)
Medical device (5996)
Medtech (6000)
Mergers & acquisitions (9361)
Metabolic disorders (257)
Neuroscience (943)
NextGen: Class of 2025 (3110)
Non-profit (2378)
Northern California (970)
Obesity (152)
Opinion (114)
People (36147)
Phase I (7804)
Phase II (11652)
Phase III (10386)
Pipeline (394)
Postmarket research (1197)
Preclinical (3805)
Press Release (63)
Radiopharmaceuticals (120)
Rare diseases (134)
Real estate (3354)
Regulatory (9533)
Research institute (1560)
Resumes & cover letters (154)
Series A (69)
Southern California (818)
Startups (2306)
United States (8591)
Vaccines (264)
Weight loss (105)
Date
Today (3)
Last 7 days (284)
Last 30 days (1249)
Last 365 days (17072)
2025 (2143)
2024 (17671)
2023 (20587)
2022 (25923)
2021 (28724)
2020 (27001)
2019 (23912)
2018 (17775)
2017 (17566)
2016 (16683)
2015 (19258)
2014 (14075)
2013 (11526)
2012 (12502)
2011 (13061)
2010 (12068)
Location
Africa (478)
Arizona (82)
Asia (21146)
Australia (3724)
California (2162)
Canada (817)
China (220)
Colorado (117)
Connecticut (80)
Delaware (71)
Europe (49320)
Florida (326)
Georgia (77)
Illinois (193)
Indiana (169)
Japan (93)
Maryland (290)
Massachusetts (1646)
Michigan (120)
Minnesota (158)
New Jersey (699)
New York (702)
North Carolina (458)
Northern California (970)
Ohio (86)
Pennsylvania (423)
South America (698)
Southern California (818)
Texas (274)
Washington State (203)
332,352 Results for "biodelivery sciences international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capitalists
Blackstone Launches New $5B+ Fund for Life Sciences
Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.
January 31, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Healthcare at a Crossroads: Maintaining Good Science in Uncertain Times
Continuing our SCOPE 2025 coverage, Rohit Nambisan, CEO at Lokavant addresses not only current challenges, but the life sciences industry’s responsibility to maintain scientific integrity.
February 17, 2025
·
1 min read
·
Lori Ellis
Deals
Collegium to Acquire BioDelivery Sciences in an All-Cash Deal
BioDelivery Sciences International, Inc. today announced that it has entered into a definitive merger agreement for Collegium Pharmaceutical, Inc.
February 14, 2022
·
6 min read
Business
Philadelphia’s Life Sciences Scene Making Its Mark
The Philadelphia market has gained recognition not only for its cell and gene therapy sector but also its real estate scene and talent pool. Vittoria Biotherapeutics, Interius BioTherapeutics and Chamber of Commerce for Greater Philadelphia executives share why the area is a life sciences hot spot.
February 20, 2025
·
7 min read
·
Angela Gabriel
Bio NC
BioDelivery Sciences International to Host ELYXYB™ Investor Day
BioDelivery Sciences International, Inc., a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced it will host a virtual ELYXYB™ Investor Day on Thursday, October 14, 2021, at 10:30am ET.
September 30, 2021
·
9 min read
Lone Star Bio
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
Cassava Sciences, Inc. today announced plans to present a virtual oral presentation at the International Conference on Alzheimer’s and Parkison’s Disease (AD/PD 2024) taking place in Lisbon, Portugal from March 5-9, 2024.
March 4, 2024
·
5 min read
Job Trends
BioSpace
Showcases Life Sciences Hubs in 2025 Hotbed Maps
BioSpace
has revealed its 2025 Hotbed Maps, showcasing nine regional hot spots for life sciences activity.
January 21, 2025
·
1 min read
·
Chantal Dresner
Biotech Beach
OKBio -- Relaunching as Life Science Oklahoma -- to participate in BIO International Convention 2024
Oklahoma’s bioscience community is announcing a relaunch of its industry association, with the new Life Science Oklahoma bringing new leadership, a new format and renewed focus and support to businesses and organizations within the Oklahoma life sciences and healthcare communities.
June 3, 2024
·
4 min read
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Achieve Life Sciences, Inc., a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced publication of the ORCA-V1 trial results in the Journal of the American Medical Association Internal Medicine.
May 6, 2024
·
9 min read
Bio NC
BioDelivery Sciences International Announces ELYXYB™ is Now Available in the U.S. for the Acute Treatment of Migraine
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), today announced the U.S. commercial launch and availability of ELYXYBTM (celecoxib oral solution), the first and only FDA-approved ready-to-use oral solution for the acute treatment of migraine with or without aura in adults.
February 24, 2022
·
8 min read
1 of 33,236
Next
